PATENT CLAIM ANALYSIS

Application Number: 15938729
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "423000"]

Abstract:
The present invention relates to a compound of formula (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-meth19243yloxime, and/or an active metabolite thereof having antagonist action at the oxytocin receptor and/or vasopressin V1a receptor, to processes for their preparation, pharmaceutical compositions containing them and their use.

Claim (Index 19):
A compound according to  claims 1 - 11 , for use in the treatment of infertility by in vitro fertilization-embryo transfer (IVF-ET) method.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.21277
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14479664', '15476325', '14571615', '14735215', '10480992']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8075928189200701
- 35 USC 102 Novelty (BERT): 0.5519135439578329
- Combined Prediction Score: 0.7820248914238463
- Mean Citation Score: 366.683408
- Max Citation Score: 432.80896
- Similarity Product: 284.6902621655274

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test